These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26374108)

  • 1. The Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study: Variation in Platelet Response to Clopidogrel and Aspirin.
    Bozzi LM; Mitchell BD; Lewis JP; Ryan KA; Herzog WR; O'Connell JR; Horenstein RB; Shuldiner AR; Yerges-Armstrong LM
    Curr Vasc Pharmacol; 2016; 14(1):116-24. PubMed ID: 26374108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention.
    Claeys MJ; Van Der Planken MG; Michiels JJ; Vertessen F; Dilling D; Bosmans JM; Vrints CJ
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):283-8. PubMed ID: 12032392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy.
    Geisler T; Zürn C; Paterok M; Göhring-Frischholz K; Bigalke B; Stellos K; Seizer P; Kraemer BF; Dippon J; May AE; Herdeg C; Gawaz M
    Eur Heart J; 2008 Jul; 29(13):1635-43. PubMed ID: 18503057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation and recruitment with aspirin-clopidogrel therapy.
    Helgason CM; Grossi E; Pandey D; Valika A; Cursio J; Brace LD
    Cerebrovasc Dis; 2008; 25(5):392-400. PubMed ID: 18349532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of platelet function in healthy cats in response to commonly prescribed antiplatelet drugs using three point-of-care platelet function tests.
    Ho KK; Abrams-Ogg AC; Wood RD; O'Sullivan ML; Kirby GM; Blois SL
    J Feline Med Surg; 2017 Jun; 19(6):638-647. PubMed ID: 27170631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.
    Lewis JP; Ryan K; O'Connell JR; Horenstein RB; Damcott CM; Gibson Q; Pollin TI; Mitchell BD; Beitelshees AL; Pakzy R; Tanner K; Parsa A; Tantry US; Bliden KP; Post WS; Faraday N; Herzog W; Gong Y; Pepine CJ; Johnson JA; Gurbel PA; Shuldiner AR
    Circ Cardiovasc Genet; 2013 Apr; 6(2):184-92. PubMed ID: 23392654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) study.
    Saw J; Madsen EH; Chan S; Maurer-Spurej E
    J Am Coll Cardiol; 2008 Dec; 52(23):1826-1833. PubMed ID: 19038679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
    Bierbach B; Horstick G; Berg O; Heimann A; Münzel T; Vahl CF; Kempski O; Darius H
    Thromb Haemost; 2006 Feb; 95(2):354-61. PubMed ID: 16502561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
    J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
    Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.
    Lev EI; Patel RT; Guthikonda S; Lopez D; Bray PF; Kleiman NS
    Thromb Res; 2007; 119(3):355-60. PubMed ID: 16581111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Importance of the Mean Platelet Aggregation Degree in Long-term Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation.
    Li Q; Ren X; Yu X; He J; Gao Y; Zhang X; Wu C; Luo Y; Zhang Y; Chen F
    Cardiovasc Ther; 2016 Jun; 34(3):127-37. PubMed ID: 26826703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PlaCor PRT measurement of shear-activated platelet aggregate formation in stable patients treated with single and dual antiplatelet therapy.
    Godino C; Pavon AG; Mangieri A; Viani GM; Galaverna S; Spartera M; Chieffo A; Cappelletti A; Margonato A; Colombo A
    Platelets; 2014; 25(5):337-42. PubMed ID: 23971989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
    Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action.
    Payne DA; Hayes PD; Jones CI; Belham P; Naylor AR; Goodall AH
    J Vasc Surg; 2002 Jun; 35(6):1204-9. PubMed ID: 12042732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic effects of a new fixed-dose clopidogrel-aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial.
    Koh JS; Park Y; Tantry US; Ahn JH; Kang MG; Kim K; Jang JY; Park HW; Park JR; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
    Platelets; 2017 Mar; 28(2):187-193. PubMed ID: 27560946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of shear-activated platelet aggregate formation in non-anticoagulated blood: utility in detection of clopidogrel-aspirin-induced platelet dysfunction.
    Johnson GJ; Sharda AV; Rao GH; Ereth MH; Laxson DD; Owen WG
    Clin Appl Thromb Hemost; 2012; 18(2):140-9. PubMed ID: 22009986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.
    Armstrong PC; Dhanji AR; Truss NJ; Zain ZN; Tucker AT; Mitchell JA; Warner TD
    Thromb Haemost; 2009 Oct; 102(4):772-8. PubMed ID: 19806265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.